Keri Lestari

991 total citations
71 papers, 679 citations indexed

About

Keri Lestari is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Keri Lestari has authored 71 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Keri Lestari's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Medication Adherence and Compliance (9 papers) and Natural Antidiabetic Agents Studies (7 papers). Keri Lestari is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Medication Adherence and Compliance (9 papers) and Natural Antidiabetic Agents Studies (7 papers). Keri Lestari collaborates with scholars based in Indonesia, Japan and Switzerland. Keri Lestari's co-authors include Rizky Abdulah, Ajeng Diantini, Eli Halimah, Melisa Intan Barliana, Ivan Surya Pradipta, Anas Subarnas, Hadyana Sukandar, Sofa D. Alfian, Herry Herman and Joseph R. Bertino and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Internet Research and Frontiers in Pharmacology.

In The Last Decade

Keri Lestari

63 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keri Lestari Indonesia 13 180 92 86 83 70 71 679
Eunhee Ji South Korea 17 314 1.7× 47 0.5× 81 0.9× 58 0.7× 87 1.2× 58 1.2k
Alaa Bagalagel Saudi Arabia 14 154 0.9× 54 0.6× 56 0.7× 50 0.6× 78 1.1× 41 540
Elena Tragni Italy 21 125 0.7× 197 2.1× 118 1.4× 90 1.1× 43 0.6× 67 1.1k
Melisa Intan Barliana Indonesia 15 132 0.7× 27 0.3× 52 0.6× 50 0.6× 67 1.0× 95 559
Elizabeth G. Wood United Kingdom 17 341 1.9× 108 1.2× 62 0.7× 171 2.1× 108 1.5× 39 1.4k
Ajeng Diantini Indonesia 16 208 1.2× 53 0.6× 30 0.3× 101 1.2× 194 2.8× 96 877
Jeremiah D. Momper United States 22 290 1.6× 45 0.5× 60 0.7× 130 1.6× 56 0.8× 86 1.4k
Sivasankaran Ponnusankar India 18 210 1.2× 109 1.2× 64 0.7× 26 0.3× 227 3.2× 88 986
Quan Zhou China 16 132 0.7× 52 0.6× 90 1.0× 40 0.5× 23 0.3× 37 857
Kevin Sneed United States 15 191 1.1× 69 0.8× 36 0.4× 80 1.0× 91 1.3× 39 1.0k

Countries citing papers authored by Keri Lestari

Since Specialization
Citations

This map shows the geographic impact of Keri Lestari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keri Lestari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keri Lestari more than expected).

Fields of papers citing papers by Keri Lestari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keri Lestari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keri Lestari. The network helps show where Keri Lestari may publish in the future.

Co-authorship network of co-authors of Keri Lestari

This figure shows the co-authorship network connecting the top 25 collaborators of Keri Lestari. A scholar is included among the top collaborators of Keri Lestari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keri Lestari. Keri Lestari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barliana, Melisa Intan, et al.. (2025). Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 18. 135–146. 1 indexed citations
2.
3.
Meiliana, Anna, et al.. (2024). The Important Role of Phosphatidylserine, ADAM17, TNF‐Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity. Journal of Obesity. 2024(1). 1424404–1424404. 3 indexed citations
4.
Lestari, Keri, et al.. (2024). Knowledge, attitude, and utilization of traditional medicine within the plural medical system in West Java, Indonesia. BMC Complementary Medicine and Therapies. 24(1). 64–64. 6 indexed citations
5.
Barliana, Melisa Intan, et al.. (2023). Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial. The Indonesian Biomedical Journal. 15(6). 366–74. 5 indexed citations
6.
Lestari, Keri, et al.. (2023). REVIEW: TONIC POTENCY OF ZINGIBERACEAE FAMILY HERBAL PLANTS IN IMPROVING BODY WELLNESS. Medical Sains Jurnal Ilmiah Kefarmasian. 8(3). 1315–1322.
7.
Meiliana, Anna, et al.. (2023). Update of cellular responses to the efferocytosis of necroptosis and pyroptosis. Cell Division. 18(1). 5–5. 18 indexed citations
8.
9.
Abdulah, Rizky, et al.. (2022). IDENTIFICATION OF FLAVONOIDS FROM ACALYPHA INDICA L. (EUPHORBIACEAE) AS CASPASE-3 ACTIVATORS USING MOLECULAR DOCKING AND MOLECULAR DYNAMICS. International Journal of Applied Pharmaceutics. 162–166. 8 indexed citations
10.
Wathoni, Nasrul, et al.. (2021). Telepharmacy: A Potential Alternative Approach for Diabetic Patients During the COVID-19 Pandemic. Journal of Multidisciplinary Healthcare. Volume 14. 2261–2273. 19 indexed citations
11.
Iskandarsyah, Aulia, et al.. (2020). Impact of pharmacist counseling on health-related quality of life of patients with type 2 diabetes mellitus: a cluster randomized controlled study. Journal of Diabetes & Metabolic Disorders. 19(2). 675–682. 10 indexed citations
12.
Lesmana, Ronny, Hanna Goenawan, Iwan Setiawan, et al.. (2018). Nutmeg Extract Increases Skeletal Muscle Mass in Aging Rats Partly via IGF1‐AKT‐mTOR Pathway and Inhibition of Autophagy. Evidence-based Complementary and Alternative Medicine. 2018(1). 2810840–2810840. 30 indexed citations
13.
Lestari, Keri, et al.. (2018). Hypoglycemia Risk Factors among Hospitalized Type 2 Diabetes Mellitus Patients. SHILAP Revista de lepidopterología. 3(2). 51–56. 1 indexed citations
14.
Muhtadi, ‪Ahmad, et al.. (2017). Consumption Time of Captopril Influenced the Outcomes of Patients with Stage 1 Hypertension. SHILAP Revista de lepidopterología. 2(1).
15.
Abdulah, Rizky, Melisa Intan Barliana, Ivan Surya Pradipta, et al.. (2014). Assessment of patient care indicators at community pharmacies in Bandung City, Indonesia.. PubMed. 45(5). 1196–201. 13 indexed citations
16.
Suwantika, Auliya A., Neily Zakiyah, Keri Lestari, & Maarten J. Postma. (2014). Accelerating the introduction of rotavirus immunization in Indonesia. Expert Review of Vaccines. 13(4). 463–472. 10 indexed citations
17.
Halimah, Eli, Ajeng Diantini, Ivan Surya Pradipta, et al.. (2014). Induction of caspase cascade pathway by kaempferol-3-O-rhamnoside in LNCaP prostate cancer cell lines. Biomedical Reports. 3(1). 115–117. 35 indexed citations
18.
Insani, Widya N., et al.. (2013). Effect of Pharmaceutical Information Care on Clinical Outcomes of Patients With Type 2 Diabetes Mellitus. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Insani, Widya N., et al.. (2013). Pengaruh Pelayanan Informasi Obat terhadap Keberhasilan Terapi Pasien Diabetes Melitus Tipe 2. Indonesian Journal of Clinical Pharmacy. 2(4). 127–135. 3 indexed citations
20.
Lestari, Keri, et al.. (2012). Monitoring Terapi Warfarin pada Pasien Pelayanan Jantung pada Rumah Sakit di Bandung. Indonesian Journal of Clinical Pharmacy. 1(3). 110–116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eunhee Ji Breakdown of academic impact, for papers by Alaa Bagalagel Breakdown of academic impact, for papers by Elena Tragni Breakdown of academic impact, for papers by Melisa Intan Barliana Breakdown of academic impact, for papers by Elizabeth G. Wood Breakdown of academic impact, for papers by Ajeng Diantini Breakdown of academic impact, for papers by Jeremiah D. Momper Breakdown of academic impact, for papers by Sivasankaran Ponnusankar Breakdown of academic impact, for papers by Quan Zhou Breakdown of academic impact, for papers by Kevin Sneed
Rankless by CCL
2026